We are using cookies This website uses cookies in order to offer you the most relevant information. By browsing this website, you accept these cookies.
HDAC inhibitors, DNA alkylators and nucleoside analogs are effective components of combination chemotherapy.
2
On the other hand, the use of alkylators and topoisomerase II inhibitors is associated with an increased risk of t-AML.
3
The protein level of MRP1 correlated with cellular resistance to busulfan and chlorambucil, and Rom exposure sensitized cells to these DNA alkylators.
4
To determine a possible mechanism of their synergism, we analyzed the effects of HDAC inhibitors on the expression of drug transporters which export DNA alkylators.